Levofloxacin treatment of the two administration methods acquired pneumonia in elderly hospital clinical analysis.docVIP

 PAGE \* MERGEFORMAT 10 Levofloxacin treatment of the two administration methods acquired pneumonia in elderly hospital clinical analysis Of: Peng Huasheng, Xu Xianhua, Wang Xiaoxiang, Shen Yu, Zhong Jing Ye, Xiao Xinrong [Abstract] Objective To compare the two kinds of levofloxacin administration method treatment of elderly hospital ward acquired pneumonia (HAP’s efficacy and safety. Methods 56 cases of elderly patients were randomly divided into 2 groups HAP treatment group (n = 28 with levofloxacin Injection 0.5g / time, 1 / d, the control group (n = 28 with injectable levofloxacin 0.3g, 2 times / d, course of treatment was 7 ~ 14d. the treatment group and control group total effective were 85.7% and 82.1%, the bacterial clearance rates were 80.8% and 80.0% in group adverse events were 14.3% and 17.9%. Conclusion levofloxacin treatment of senile HAP two administration methods is effective, adverse reactions few and minor, for the treatment of hospital-acquired pneumonia in elderly patients with first-line drugs. [Keywords:] levofloxacin, two administration methods, age, hospital acquired pneumonia Abstract Objective To compared the clinical efficacy and safety of twe injected methods of levofloxacin in treatment of elderly patients with hospital acquired pneumonia.Methods Fifty-eight elderly patients with hospital acquired pneumonia were divided into two groups in random.The therapy group was injected with levofloxacin 0.5g, qd, the control group was injected with levofloxacin 0.3gg, bid.Both courses of treatment were 7 ~ 14 days.Results The total efficacy rates in the therapy and control groups were 85.7% and 82.1%, respectively.The clearance rates of bacteria were 80.8% and 80.0%, respectively.And the rates of side effects were 14.3% and 17.9%, respectively.Conclusions Twe injected methods of levofloxacin in treatment of elderly patients with HAP are effective and safe, it can be used as the first choice drug in the treatment of elderly patient